Diabetes affects nearly 24 million people in the United States, most with Type 2 diabetes, a disease which is often coupled with obesity. Concerned by the increasing number of overweight Americans, nutrition experts with the UC San Diego School of Medicine are launching Take Charge, a research study analyzing the effectiveness of a commercial weight-loss program on participants with Type 2 diabetes who have a BMI of 25 – 45.
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, report that significant numbers of myofibroblasts – cells that produce the fibrous scarring in chronic liver injury – revert to an inactive phenotype as the liver heals. The discovery in mouse models could ultimately help lead to new human therapies for reversing fibrosis in the liver, and in other organs like the lungs and kidneys.
On May 3, 2012, Rady Children’s Hospital-San Diego and the UC San Diego School of Medicine launched the Center for the Promotion of Maternal Health and Infant Development. The new center, located on the campus of Rady Children’s Hospital at 7910 Frost Street in San Diego, will focus on identifying the best ways to optimize pregnancy outcomes and to improve the health of children in San Diego through groundbreaking research and patient care.
Invasive and costly tests commonly performed on women before surgery for stress urinary incontinence (SUI) may not be necessary, according to researchers at the University of California San Diego, School of Medicine and the Urinary Incontinence Treatment Network. The study, supported by the National Institutes of Health (NIH), will be released online May 2 by the New England Journal of Medicine (NEJM).
Paul S. Viviano has accepted the position as the new CEO of UC San Diego Health System and associate vice chancellor for Health Sciences. His appointment was approved by the UC Board of Regents, and will commence June 1, 2012.
In the online May 2 issue of the journal Cell Metabolism, researchers at the University of California, San Diego School of Medicine publish three distinct articles exploring: the complex interactions of lipids and inflammation in insulin resistance; the roles of omega 3 fatty acids and a particular gene in fighting inflammation;how elevated levels of a particular protein might delay the muscle-destroying effects of amyotrophic lateral sclerosis.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
